Integer Holdings Corporation · NYSE:ITGR

Integer — Greatbatch — Innovations in Neuromodulation: Venture Capital Panel (INS) (June 2015)

13 slides from Integer's conference presentation, Jun 6, 2015

1. Slide 1: Innovations In Neuromodulation: Venture Capital Panel

   Innovations In Neuromodulation: Venture Capital Panel June 6, 2015 Tony Borowicz VP, Business Development

2. Slide 2: Greatbatch As A Core Partner

   Greatbatch As A Core Partner Batteries | Capacitors | Catheters | Stimulation Leads | Feedthroughs Device Enclosures & Cases | Device Headers | Device Assembly Advanced Coatings | Introducers | Orthopaedic Trays, Cases & Implants Header Enclosure Battery Feedthrough Stimulation Leads

3. Slide 3: Who We Serve

   Who We Serve cBostone, , A> Medtronic nee ST. JUDE MEDICAL Wi Cyberonics — fokmenafohnen NeEvro PHILIPS (J) smmer a8 BIOTRONIK O coreFusion stryker SORIN [c dl COVIDIEN Baxter >¢ smith&nephew Carestream = HALLIBURTON =ieM=5 ZOLL. st Greatbatch

4. Slide 4: How We Partner

   How We Partner Segment Offering Develops and commercializes high-value neural interface technology, components and systems for neuroscience and clinical applications Develops and manufactures complete medical devices, including active implantable medical devices for neuromodulation Designs and devel

5. Slide 5: R&D Neural Interface

   R&D Neural Interface Develops advanced technologies and devices for Neuroscience & Neurostimulation research markets Basic science & Applied science & Clinical translational technology studies technology studies studies Thin-film electrodes NeuroNexus powers the R&D leading to next-generation neuros

6. Slide 6: Device Development & Manufacturing

   Device Development & Manufacturing Proven Fully Integrated Turn-key Medical Development Manufacturing Quality System Manufacturing Platform Facility  Fast prototyping  Sensing  Class 7 & 8 clean  ISO 13485:2003  Full product design &  Stimulation areas certified (BSI) development  Communicati

7. Slide 7: System Platform R&D

   System Platform R&D Design & development of complete neurostimulation system platforms  IPGs  Leads  Programmers  Software  Accessories QiG Group empowers the creative design, development and speed to market of new medical devices in strategic markets

8. Slide 8: Design & Manufacturing

   Design & Manufacturing  Component, value-added-assembly & full system manufacturing  FDA Registered Facility / Regulatory: ISO13485:2003, CMDCAS, AIMD & MDD Greatbatch Medical is committed to the design and manufacture of critical technologies that enhance the reliability and performance of medica

9. Slide 9: GB Ventures: Strategic Investments

   Strategic Investments GB Ventures Minority Equity Strategic Investment Philosophy  $2 – 5M targeted investments  3 – 5 targeted deals per year  Typically board observer seat  < 20% ownership equity positions nor maintain controlling interest Cardiac Neuromodulation Orthopaedics Vascular Portable

10. Slide 10: GB Ventures: How We Invest

    How We Invest GB Ventures Creating a ‘Win – Win’ Partnership Investment Return Cash Equity Royalty, Additional Equity, Innovations & IP Alternate Fields of Use Product Development Services NRE Funding Manufacturing Capabilities Exclusive Long Term Agreement Commercialization Avenues Exclusive Distri

11. Slide 11: Positioned for Neurostimulation Partnerships

    Positioned for Neurostimulation Partnerships Early Stage Innovation Medical Device Components Medical Device Systems  Equity investments  Leads  Platform system reduces  Research  Batteries time and risk to market  Prototyping  Feed throughs  Other Neurostimulation indications  Component ma

12. Slide 12: Our Story

    Our Story  One-stop shop for long-term strategic partnerships from early stage investments through commercialization  Multi-faceted mechanisms supporting: › Investments › Research › Technology development › Clinical trials › Manufacturing  History as world-class component supplier  Next generati

13. Slide 13: Thank you!

    Thank you! Innovations In Neuromodulation: Venture Capital Panel June 6, 2015 Tony Borowicz VP, Business Development

Greatbatch — Innovations in Neuromodulation: Venture Capital Panel (INS) (June 2015) on 6ix